Company / CIK 0001793229
Claritev Corp
- Ticker
- CTEV
- Size, estimated from filings
- Small cap ($300M – $2B)
- Insiders on file
- 7
- Federal contracts on record
- none matched
- Lobbying filings on record
- 5
- SEC filings
- EDGAR ↗
- Latest trade on record
- October 26, 2026
Claritev Corp (CTEV) has 7 insiders on file who disclosed 15 transactions in the last 12 months (6 open-market buys, 7 sales, about $5.0M at reported prices). No federal contract award that started in the last 180 days was found for a recipient with exactly this name, and 3 lobbying filings naming it as client report $180K in 2026.
Claritev Corp in charts
Who is trading this stock
Which people account for the buying and selling over the last 12 months?
5 people account for the disclosed buying and selling in Claritev Corp over the last 12 months; the most active is ARES MANAGEMENT LLC with $1.7M.
Lobbying spend by quarter
How much has Claritev Corp reported spending on federal lobbying?
Claritev Corp reported $260K in lobbying over the last eight quarters, from filings matched by exact company name.
Insiders
| Name | Role | Rows | Bought | Sold | Last filed |
|---|---|---|---|---|---|
| ARES MANAGEMENT LLC | Insider | 4 | 2 | 0 | October 27, 2026 |
| Main Jennifer Elizabeth | Director | 1 | 0 | 0 | October 19, 2026 |
| Misencik Tiffani | SVP, Chief Growth Officer | 3 | 0 | 3 | October 16, 2026 |
| Garis Douglas Michael | EVP&CFO | 2 | 0 | 2 | September 22, 2026 |
| Letham Thomas Benjamin | Director | 1 | 0 | 0 | September 16, 2026 |
| Dalton Travis | Pres., CEO & Executive Chair | 2 | 2 | 0 | August 31, 2026 |
| Mintz William B. | SVP, Chief Strategy Officer | 2 | 0 | 2 | August 12, 2026 |
Rows are this company's Form 4 rows for each person. "Bought" and "sold" count open-market purchases (code P) and sales only. More in insider buying and insider selling.
Insider transactions
| Filer | Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARES MANAGEMENT LLC | CTEV | Other P | October 26, 2026 | October 27, 2026 | 1d | 20,834 | $24 | $501K | indirectalso in another filing | Form 4 ↗ | |
| ARES MANAGEMENT LLC | CTEV | Other P | October 23, 2026 | October 27, 2026 | 4d | 50,000 | $24 | $1.2M | indirectalso in another filing | Form 4 ↗ | |
| ARES MANAGEMENT LLC | CTEV | Buy P | October 26, 2026 | October 27, 2026 | 1d | 20,834 | $24 | $501K | indirect | Form 4 ↗ | |
| ARES MANAGEMENT LLC | CTEV | Buy P | October 23, 2026 | October 27, 2026 | 4d | 50,000 | $24 | $1.2M | indirect | Form 4 ↗ | |
| Main Jennifer Elizabeth | CTEV | Other A | October 15, 2026 | October 19, 2026 | 4d | 3,113 | — | — | Form 4 ↗ | ||
| Misencik Tiffani | CTEV | Sell S | October 15, 2026 | October 16, 2026 | 1d | 5,812 | $24 | $138K | 10b5-1 plan | Form 4 ↗ | |
| Misencik Tiffani | CTEV | Sell F | October 14, 2026 | October 16, 2026 | 2d | 9,994 | $24 | $239K | 10b5-1 plan | Form 4 ↗ | |
| Garis Douglas Michael | CTEV | Sell S | September 21, 2026 | September 22, 2026 | 1d | 1,148 | $31 | $36K | 10b5-1 plan | Form 4 ↗ | |
| Garis Douglas Michael | CTEV | Sell S | September 21, 2026 | September 22, 2026 | 1d | 7,877 | $31 | $240K | 10b5-1 plan | Form 4 ↗ | |
| Letham Thomas Benjamin | CTEV | Other A | September 14, 2026 | September 16, 2026 | 2d | 2,880 | — | — | Form 4 ↗ | ||
| Dalton Travis | CTEV | Buy P | August 28, 2026 | August 31, 2026 | 3d | 1,950 | $38 | $75K | indirect | Form 4 ↗ | |
| Dalton Travis | CTEV | Buy P | August 27, 2026 | August 31, 2026 | 4d | 4,500 | $39 | $175K | indirect | Form 4 ↗ | |
| Misencik Tiffani | CTEV | Sell S | August 14, 2026 | August 18, 2026 | 4d | 8,850 | $40 | $355K | Form 4 ↗ | ||
| Mintz William B. | CTEV | Sell S | August 10, 2026 | August 12, 2026 | 2d | 8,431 | $34 | $289K | Form 4 ↗ | ||
| Mintz William B. | CTEV | Sell F | August 5, 2026 | August 7, 2026 | 2d | 3,622 | $26 | $95K | Form 4 ↗ |
Federal contracts (USAspending, awards started in the last 180 days)
No contract award starting in the last 180 days was found for a recipient named exactly "Claritev Corp". Subsidiaries and differently-spelled recipients are not matched — search contracts.
Lobbying (Senate LDA, as client)
| Period | Registrant | Primary issue | Amount | Source |
|---|---|---|---|---|
| 2026 Q3 | ALSTON & BIRD LLP | Health Issues | $60,000 | LDA ↗ |
| 2026 Q2 | ALSTON & BIRD LLP | Health Issues | $60,000 | LDA ↗ |
| 2026 Q1 | ALSTON & BIRD LLP | Health Issues | $60,000 | LDA ↗ |
| 2025 Q4 | ALSTON & BIRD LLP | Health Issues | $40,000 | LDA ↗ |
| 2025 Q3 | ALSTON & BIRD LLP | Health Issues | $40,000 | LDA ↗ |
Related companies
Companies whose stock was traded by the same people who traded CTEV, by number of filers in common. It shows overlap in public filings and nothing else.
- Savers Value Village, Inc. SVV 1 filer in common
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Lobbying disclosure reports Reports are due about 20 days after each quarter ends.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 10 | 15 | August 7, 2026 | October 27, 2026 | Form 4 list on EDGAR |
| Lobbying disclosure filings | 5 filings | — | — | — | LDA.gov search |
Site built November 12, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Insiders and their transactions come from SEC EDGAR Form 4 filings for this issuer. Contracts and lobbying are matched by exact normalized name (suffixes like Inc./Corp. ignored) to USAspending recipients and LDA clients — a conservative match that misses subsidiaries on purpose. See methodology and corrections.
Not investment advice. Public records shown as filed; no recommendation is made or implied.